Elimination of GD3 synthase improves memory and reduces amyloid-β plaque load in transgenic mice

Memory deficits associated with senescence: A neurophysiological and behavioral study in the rat.

Barnes, C. A. (1979) · Journal of Comparative and Physiological Psychology · doi:10.1037/h0077579 · Cited by 2,088 · see citing works

Activation of microglial cells by β-amyloid protein and interferon-γ

Meda, L., Cassatella, M. A., Szendrei, G. I., Otvos, L., Baron, P., Villalba, M., Ferrari, D., & Rossi, F. (1995) · Nature · doi:10.1038/374647a0 · Cited by 1,314 · see citing works

Relationship of microglia and astrocytes to amyloid deposits of Alzheimer disease

Itagaki, S., McGeer, P. L., Akiyama, H., Zhu, S., & Selkoe, D. (1989) · Journal of Neuroimmunology · doi:10.1016/0165-5728(89)90115-x · Cited by 940 · see citing works

Targeting of cell-surface β-amyloid precursor protein to lysosomes: alternative processing into amyloid-bearing fragments

Haass, C., Koo, E. H., Mellon, A., Hung, A. Y., & Selkoe, D. J. (1992) · Nature · doi:10.1038/357500a0 · Cited by 899 · see citing works

GM1 ganglioside–bound amyloid β–protein (Aβ): A possible form of preamyloid in Alzheimer's disease

Yanagisawa, K., Odaka, A., Suzuki, N., & Ihara, Y. (1995) · Nature Medicine · doi:10.1038/nm1095-1062 · Cited by 544 · see citing works

The Use of Sep‐Pak™ C 18 Cartridges During the Isolation of Gangliosides

Williams, M. A., & McCluer, R. H. (1980) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1980.tb12515.x · Cited by 475 · see citing works

Primary culture of identified neurons from the visual cortex of postnatal rats

Huettner, J., & Baughman, R. (1986) · Journal of Neuroscience · doi:10.1523/jneurosci.06-10-03044.1986 · Cited by 444 · see citing works

Formation of Isoprostane-like Compounds (Neuroprostanes) in Vivo from Docosahexaenoic Acid*

Roberts, L., Montine, T., Markesbery, W., Tapper, A. R., Hardy, P., Chemtob, S., Dettbarn, W., & Morrow, J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.22.13605 · Cited by 430 · see citing works

Spatial learning and memory processes: the search for their neurobiological mechanisms in the rat

Barnes, C. A. (1988) · Trends in Neurosciences · doi:10.1016/0166-2236(88)90143-9 · Cited by 421 · see citing works

Requirement for GD3 Ganglioside in CD95- and Ceramide-Induced Apoptosis

Maria, R. D., Lenti, L., Malisan, F., D’Agostino, F., Tomassini, B., Zeuner, A., Rippo, M. R., & Testi, R. (1997) · Science · doi:10.1126/science.277.5332.1652 · Cited by 421 · see citing works

Cholesterol-dependent Formation of GM1 Ganglioside-bound Amyloid β-Protein, an Endogenous Seed for Alzheimer Amyloid

Kakio, A., Nishimoto, S., Yanagisawa, K., Kozutsumi, Y., & Matsuzaki, K. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100252200 · Cited by 406 · see citing works

Interactions of Amyloid β-Protein with Various Gangliosides in Raft-Like Membranes: Importance of GM1 Ganglioside-Bound Form as an Endogenous Seed for Alzheimer Amyloid

Kakio, A., Nishimoto, S., Yanagisawa, K., Kozutsumi, Y., & Matsuzaki, K. (2002) · Biochemistry · doi:10.1021/bi0255874 · Cited by 387 · see citing works

Hyperactivity and Intact Hippocampus-Dependent Learning in Mice Lacking the M1Muscarinic Acetylcholine Receptor

Miyakawa, T., Yamada, M., Duttaroy, A., & Wess, J. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-14-05239.2001 · Cited by 366 · see citing works

Gangliosides of human, bovine, and rabbit plasma

Yu, R. K., & Ledeen, R. W. (1972) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)39374-3 · Cited by 353 · see citing works

Membrane Disruption by Alzheimer β-Amyloid Peptides Mediated through Specific Binding to Either Phospholipids or Gangliosides

McLaurin, J., & Chakrabartty, A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.43.26482 · Cited by 333 · see citing works

Novel Therapeutic Approach for the Treatment of Alzheimer's Disease by Peripheral Administration of Agents with an Affinity to β-Amyloid

Matsuoka, Y., Saito, M., LaFrancois, J. J., Saito, M., Gaynor, K., Olm, V., Wang, L., Casey, E., Lu, Y., Shiratori, C., et al. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-01-00029.2003 · Cited by 324 · see citing works

Impaired spatial learning in the APP_Swe + PSEN1ΔE9 bigenic mouse model of Alzheimer’s disease

Reiserer, R. S., Harrison, F. E., Syverud, D. C., & McDonald, M. P. (2007) · Genes, Brain and Behavior · doi:10.1111/j.1601-183x.2006.00221.x · Cited by 324 · see citing works

Acceleration of Amyloid Fibril Formation by Specific Binding of Aβ-(1–40) Peptide to Ganglioside-containing Membrane Vesicles

Choo, L.-P., Garzon-Rodriguez, W., Glabe, C. G., & Surewicz, W. K. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.37.22987 · Cited by 312 · see citing works

Mitochondrial dysfunction, apoptotic cell death, and Alzheimer’s disease

Eckert, A., Keil, U., Marques, C. A., Bonert, A., Frey, C., Schüssel, K., & Müller, W. E. (2003) · Biochemical Pharmacology · doi:10.1016/s0006-2952(03)00534-3 · Cited by 309 · see citing works

Comparative cytoarchitectonic atlas of the C57BL/6 and 129/Sv mouse brains

Hof, P. R. (2000) · Elsevier eBooks · Cited by 289 · see citing works

Behavioral profiles of inbred strains on novel olfactory, spatial and emotional tests for reference memory in mice

Holmes, A., Wrenn, C. C., Harris, A. P., Thayer, K. E., & Crawley, J. N. (2002) · Genes Brain & Behavior · doi:10.1046/j.1601-1848.2001.00005.x · Cited by 275 · see citing works

Spatial and nonspatial escape strategies in the Barnes mazePreprint

Harrison, F. E., Reiserer, R. S., Tomarken, A. J., & McDonald, M. P. (2006) · Learning & Memory · doi:10.1101/lm.334306 · Cited by 245 · see citing works

A Seed for Alzheimer Amyloid in the Brain

Hayashi, H., Kimura, N., Yamaguchi, H., Hasegawa, K., Yokoseki, T., Shibata, M. S., Yamamoto, N., Michikawa, M., Yoshikawa, Y., Terao, K., et al. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.0861-04.2004 · Cited by 239 · see citing works

Mice Expressing Only Monosialoganglioside GM3 Exhibit Lethal Audiogenic Seizures

Kawai, H., Allende, M. L., Wada, R., Kono, M., Sango, K., Deng, C., Miyakawa, T., Crawley, J. N., Werth, N., Bierfreund, U., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.c000847200 · Cited by 228 · see citing works

Interactions of Amyloid β-Peptide (1−40) with Ganglioside-Containing Membranes

Matsuzaki, K., & Horikiri, C. (1999) · Biochemistry · doi:10.1021/bi982345o · Cited by 217 · see citing works

Raft lipids as common components of human extracellular amyloid fibrils

Gellermann, G. P., Appel, T. R., Tannert, A., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407035102 · Cited by 207 · see citing works

Aβ-Induced Inflammatory Processes in Microglia Cells of APP23 Transgenic Mice

Bornemann, K. D., Wiederhold, K., Pauli, C., Ermini, F., Stalder, M., Schnell, L., Sommer, B., Jucker, M., & Staufenbiel, M. (2001) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63945-4 · Cited by 204 · see citing works

Mice lacking both subunits of lysosomal β–hexosaminidase display gangliosidosis and mucopolysaccharidosis

Sango, K., McDonald, M. P., Crawley, J. N., et al. (1996) · Nature Genetics · doi:10.1038/ng1196-348 · Cited by 202 · see citing works

Direct interaction of GD3 ganglioside with mitochondria generates reactive oxygen species followed by mitochondrial permeability transition, cytochrome c release, and caspase activation

García‐Ruiz, C., Colell, A., Parı́s, R., & Fernández-Checa, J. C. (2000) · The FASEB Journal · doi:10.1096/fasebj.14.7.847 · Cited by 197 · see citing works

Structural Transitions Associated with the Interaction of Alzheimer β-Amyloid Peptides with Gangliosides

McLaurin, J., Franklin, T., Fraser, P. E., & Chakrabartty, A. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.8.4506 · Cited by 188 · see citing works

The interaction between Alzheimer amyloid β(1–40) peptide and ganglioside GM1‐containing membranes

Choo, L.-P., & Surewicz, W. K. (1997) · FEBS Letters · doi:10.1016/s0014-5793(96)01504-9 · Cited by 178 · see citing works

Neurogranin null mutant mice display performance deficits on spatial learning tasks with anxiety related components

Miyakawa, T., Yared, E., Pak, J. H., Huang, F. L., Huang, K., & Crawley, J. N. (2001) · Hippocampus · doi:10.1002/hipo.1092 · Cited by 178 · see citing works

Immunoelectron microscopic study of synaptic pathology in Alzheimer's disease

Masliah, E., Hansen, L. A., Albright, T., Mallory, M. E., & Terry, R. D. (1991) · Acta Neuropathologica · doi:10.1007/bf00293464 · Cited by 174 · see citing works

Exploratory activity and spatial learning in 12-month-old APP695SWE/co+PS1/ΔE9 mice with amyloid plaques

Lalonde, R., Kim, H. D., Maxwell, J. A., & Fukuchi, K. (2005) · Neuroscience Letters · doi:10.1016/j.neulet.2005.08.028 · Cited by 170 · see citing works

Commitment to Apoptosis by GD3 Ganglioside Depends on Opening of the Mitochondrial Permeability Transition Pore

Scorrano, L., Petronilli, V., Lisa, F. D., & Bernardi, P. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.32.22581 · Cited by 161 · see citing works

Characterization of High-Affinity Binding between Gangliosides and Amyloid β-Protein

Ariga, T., Kobayashi, K., Hasegawa, A., Kiso, M., Ishida, H., & Miyatake, T. (2001) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.2001.2304 · Cited by 158 · see citing works

Adaptation of the circular platform spatial memory task for mice: use in detecting cognitive impairment in the APPSW transgenic mouse model for Alzheimer’s disease

Pompl, P. N., MULLAN, M. J., Bjugstad, K. B., & Arendash, G. W. (1999) · Journal of Neuroscience Methods · doi:10.1016/s0165-0270(98)00169-1 · Cited by 149 · see citing works

Cycloxygenase-2 activity promotes cognitive deficits but not increased amyloid burden in a model of Alzheimer’s disease in a sex-dimorphic pattern

Melnikova, T., Savonenko, A. V., Wang, Q., Liang, X., Hand, T. A., Wu, L., Kaufmann, W. E., Vehmas, A. K., & Andreasson, K. I. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2006.05.001 · Cited by 134 · see citing works

Apoptogenic Ganglioside GD3 Directly Induces the Mitochondrial Permeability Transition

Kristal, B. S., & Brown, A. M. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.33.23169 · Cited by 129 · see citing works

Alzheimer Disease – Effect of Continuous Intracerebroventricular Treatment with GM1 Ganglioside and a Systematic Activation Programme

Svennerholm, L., Bråne, G., Karlsson, I., Lekman, A., Ramström, I., & Wikkelsö, C. (2002) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000063604 · Cited by 126 · see citing works

GM1 ganglioside-mediated accumulation of amyloid β-protein on cell membranes

Wakabayashi, M., Okada, T., Kozutsumi, Y., & Matsuzaki, K. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.01.060 · Cited by 125 · see citing works

Cortical distribution of gangliosides in Alzheimer's disease

Kraĉun, I., Bognar, S. K., Talan-Hranilović, J., & Ćosović, Č. (1992) · Neurochemistry International · doi:10.1016/0197-0186(92)90058-y · Cited by 125 · see citing works

Inhibition of Glycosphingolipid Biosynthesis Reduces Secretion of the β-Amyloid Precursor Protein and Amyloid β-Peptide*[boxs]

Tamboli, I. Y., Prager, K., Barth, E., Heneka, M. T., Sandhoff, K., & Walter, J. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m414525200 · Cited by 122 · see citing works

Exploratory activity, anxiety, and motor coordination in bigenic APPswe + PS1/ΔE9 mice

Lalonde, R., Kim, H. D., & Fukuchi, K. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2004.07.069 · Cited by 121 · see citing works

Amyloid β oligomerization is induced by brain lipid rafts

Kim, S., Yi, J.-S., & Ko, Y. (2006) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20978 · Cited by 118 · see citing works

Guillain-Barré syndrome associated with high titers of anti-GM1 antibodies

Nobile‐Orazio, E., Carpo, M., Meucci, N., et al. (1992) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(92)90169-l · Cited by 104 · see citing works

Mouse model of G M2 activator deficiency manifests cerebellar pathology and motor impairment

Liu, Y., Hoffmann, A., Grinberg, A., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.15.8138 · Cited by 104 · see citing works

GM1 ganglioside prevents seizures, Na+,K+-ATPase activity inhibition and oxidative stress induced by glutaric acid and pentylenetetrazole

Fighera, M. R., Royes, L. F. F., Furian, A. F., et al. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.01.002 · Cited by 100 · see citing works

BACE1 inhibition reduces endogenous Abeta and alters APP processing in wild‐type mice2

Nishitomi, K., Sakaguchi, G., Horikoshi, Y., Gray, A. J., Maeda, M., Hirata‐Fukae, C., Becker, A. G., Hosono, M., Sakaguchi, I., Minami, S., et al. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04178.x · Cited by 97 · see citing works

Effects of ganglioside treatment in rats with a lesion of the cholinergic forebrain nuclei

Casamenti, F., Bracco, L., Bartolini, L., & Pepeu, G. (1985) · Brain Research · doi:10.1016/0006-8993(85)90246-x · Cited by 91 · see citing works

β-Amyloid-Induced Synthesis of the Ganglioside Gd3 Is a Requisite for Cell Cycle Reactivation and Apoptosis in Neurons

Copani, A., Melchiorri, D., Caricasole, A., Martini, F., Sale, P., Carnevale, R., Gradini, R., Sortino, M. A., Lenti, L., Maria, R. D., et al. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-10-03963.2002 · Cited by 90 · see citing works

The correlation between neurotoxicity, aggregative ability and secondary structure studied by sequence truncated Aβ peptides

Liao, M. Q., Tzeng, Y., Chang, L. Y. X., Huang, H., Lin, T.-C., Chyan, C. L., & Chen, Y. C. (2007) · FEBS Letters · doi:10.1016/j.febslet.2007.02.026 · Cited by 90 · see citing works

Development of A$beta; terminal end-specific antibodies and sensitive ELISA for A$beta; variant

Horikoshi, Y., Sakaguchi, G., Becker, A. G., Gray, A. J., Duff, K., Aisen, P. S. S., Yamaguchi, H., Maeda, M., Kinoshita, N., & Matsuoka, Y. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.05.051 · Cited by 89 · see citing works

Brain gangliosides and memory formation

Rahmann, H. (1995) · Behavioural Brain Research · doi:10.1016/0166-4328(94)00131-x · Cited by 86 · see citing works

Present Imperfect: A Critical Review of Animal Models of the Mnemonic Impairments in Alzheimer's Disease

McDonald, M. P., & Overmier, J. B. (1997) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(97)00024-9 · Cited by 85 · see citing works

Effects of an exogenous β-amyloid peptide on retention for spatial learning

McDonald, M. P., Dahl, E. E., Overmier, J. B., Mantyh, P. W., & Cleary, J. P. (1994) · Behavioral and Neural Biology · doi:10.1016/s0163-1047(05)80059-7 · Cited by 80 · see citing works

Parkinson's disease Improved function with GMl ganglioside treatment in a randomized placebo‐controlled study

Schneider, J. S., Roeltgen, D. P., Mancall, E. L., et al. (1998) · Neurology · doi:10.1212/wnl.50.6.1630 · Cited by 78 · see citing works

Gangliosides prevent excitotoxicity through activation of TrkB receptor

Bachis, A., Rabin, S. J., Fiacco, M. D., & Mocchetti, I. (2002) · Neurotoxicity Research · doi:10.1080/10298420290015836 · Cited by 71 · see citing works

Amyloid cored plaques in Tg2576 transgenic mice are characterized by giant plaques, slightly activated microglia, and the lack of paired helical filament-typed, dystrophic neurites

Sasaki, A., Shoji, M., Harigaya, Y., Kawarabayashi, T., Ikeda, M., Naito, M., Matsubara, E., Abe, K., & Nakazato, Y. (2002) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-002-0643-8 · Cited by 61 · see citing works

Selective working memory impairments following intradentate injection of colchicine: attenuation of the behavioral but not the neuropathological effects by gangliosides GM1 and AGF2

Emerich, D. F., & Walsh, T. J. (1989) · Physiology & Behavior · doi:10.1016/0031-9384(89)90170-4 · Cited by 60 · see citing works

Impaired spatial memory in APP-overexpressing mice on a homocysteinemia-inducing diet

Bernardo, A., McCord, M. C., Troen, A. M., Allison, J. D., & McDonald, M. P. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.05.035 · Cited by 60 · see citing works

Coadministration of Galanin Antagonist M40 with a Muscarinic M1Agonist Improves Delayed Nonmatching to Position Choice Accuracy in Rats with Cholinergic Lesions

McDonald, M. P., Willard, L. B., Wenk, G. L., & Crawley, J. N. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-13-05078.1998 · Cited by 60 · see citing works

Aggregation of liposomes induced by the toxic peptides Alzheimer’s Aβs, human amylin and prion (106–126): facilitation by membrane-bound GM1 ganglioside

Kurganov, B. I., Doh, M., & Arispe, N. J. (2004) · Peptides · doi:10.1016/j.peptides.2004.01.001 · Cited by 59 · see citing works

Growth Factors and Gangliosides as Neuroprotective Agents in Excitotoxicity and Ischemia*

Hicks, D., Heidinger, V., Mohand‐Saïd, S., et al. (1998) · General Pharmacology The Vascular System · doi:10.1016/s0306-3623(97)00356-x · Cited by 54 · see citing works

Intrahippocampal Injections of Exogenous β-Amyloid Induce Postdelay Errors in an Eight-Arm Radial Maze

Sweeney, W. A., Luedtke, J., McDonald, M. P., & Overmier, J. B. (1997) · Neurobiology of Learning and Memory · doi:10.1006/nlme.1997.3770 · Cited by 53 · see citing works

The Effect of Cholesterol and Monosialoganglioside (GM1) on the Release and Aggregation of Amyloid β-Peptide from Liposomes Prepared from Brain Membrane-like Lipids

Tashima, Y., Oe, R., Lee, S., Sugihara, G., Chambers, E. J., Takahashi, M., & Yamada, T. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m308622200 · Cited by 52 · see citing works

Intracerebroventricular Administration of GM1 Ganglioside to Presenile Alzheimer Patients

Augustinsson, L.-E., Blennow, K., Blomstrand, C., et al. (1996) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000106597 · Cited by 51 · see citing works

Ganglioside GM1 attenuates scopolamine-induced amnesia in rats and mice

Silva, R. H., Felício, L. F., & Frussa‐Filho, R. (1999) · Psychopharmacology · doi:10.1007/s002130050814 · Cited by 50 · see citing works

Regional distribution of brain gangliosides in Alzheimer's disease.

Bognar, S. K., Kraĉun, I., Rösner, H., & Ćosović, Č. (1991) · PubMed · Cited by 49 · see citing works

GM1 Inhibits Amyloid β-Protein-Induced Cytokine Release

Ariga, T., & Yu, R. K. (1999) · Neurochemical Research · doi:10.1023/a:1022557920150 · Cited by 44 · see citing works

GM1 ganglioside protects nucleus basalis from excitotoxin damage: Reduced cortical cholinergic losses and animal mortality

Mahadik, S. P., Vilim, F. S., Korenovsky, A., et al. (1988) · Journal of Neuroscience Research · doi:10.1002/jnr.490200411 · Cited by 42 · see citing works

GM1 ganglioside improves spatial learning and memory of aged rats

Fong, T. G., Neff, N. H., & Hadjiconstantinou, M. (1997) · Behavioural Brain Research · doi:10.1016/s0166-4328(97)87584-5 · Cited by 40 · see citing works

Motoneuron-disease-like disorder after ganglioside therapy

Scarlato, G., Nobile‐Orazio, E., Yuki, N., et al. (1991) · The Lancet · doi:10.1016/0140-6736(91)90453-v · Cited by 40 · see citing works

Motoneuron-disease-like disorder after ganglioside therapy

Yuki, N., Sato, S., Miyatake, T., et al. (1991) · The Lancet · doi:10.1016/0140-6736(91)91767-o · Cited by 40 · see citing works

Amyloid precursor protein truncated at any of the ?-secretase sites is not cleaved to ?-amyloid

Paganetti, P., Lis, M., Klafki, H.-W., & Staufenbiel, M. (1996) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19961101)46:3 · Cited by 39 · see citing works

Analysis of galanin and the galanin antagonist M40 on delayed non-matching-to-position performance in rats lesioned with the cholinergic immunotoxin ¹⁹²IgG-Saporin.

McDonald, M. P., Wenk, G. L., & Crawley, J. N. (1997) · Behavioral Neuroscience · doi:10.1037/0735-7044.111.3.552 · Cited by 37 · see citing works

Characterization of tumor-associated fucogangliosides from PC 12 pheochromocytoma cells.

Ariga, T., Kobayashi, K., Kuroda, Y., et al. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)47916-1 · Cited by 36 · see citing works

Studies of glial lineage and proliferation in vitro using an early marker for committed oligodendrocytes

Knapp, P. E. (1991) · Journal of Neuroscience Research · doi:10.1002/jnr.490300209 · Cited by 36 · see citing works

Prevention of neuronal apoptotic death by neurotrophic agents and ganglioside GM1: insights and speculations regarding a common mechanism.

Ferrari, G. V. D., & La, G. (1996) · PubMed · Cited by 36 · see citing works

The Ganglioside GD3 as the Greek Goddess Hecate: Several Faces Turned Towards as Many Directions

Malisan, F., & Testi, R. (2005) · IUBMB Life · doi:10.1080/15216540500167179 · Cited by 31 · see citing works

Effect of Ganglioside (GM1) on Memory in Senescent Rats

Silva, R. H., Felício, L. F., Nasello, A. G., Vital, M. A. B. F., & Frussa‐Filho, R. (1996) · Neurobiology of Aging · doi:10.1016/0197-4580(96)00065-6 · Cited by 30 · see citing works

Systemic treatments with GM1 ganglioside reduce quinolinic acid-induced striatal lesions in the rat

Lombardi, G., Zanoni, R., & Moroni, F. (1989) · European Journal of Pharmacology · doi:10.1016/0014-2999(89)90883-2 · Cited by 29 · see citing works

A double-blind, placebo-controlled crossover study of ganglioside GM1 treatment for Alzheimer's disease

Flicker, C., Ferris, S. H., Kalkstein, D., et al. (1994) · American Journal of Psychiatry · doi:10.1176/ajp.151.1.126 · Cited by 27 · see citing works

Reversal of β-Amyloid-Induced Retention Deficit after Exposure to Training and State Cues

McDonald, M. P., Overmier, J. B., Bandyopadhyay, S., et al. (1996) · Neurobiology of Learning and Memory · doi:10.1006/nlme.1996.0004 · Cited by 26 · see citing works

GM1 ganglioside attenuates the behavioral deficits but not the granule cell damage produced by intradentate colchicine

Walsh, T. J., Emerich, D. F., & Schmechel, D. E. (1989) · Brain Research · doi:10.1016/0006-8993(89)91473-x · Cited by 25 · see citing works

Death of cultured hippocampal pyramidal neurons induced by pathological activation of N-methyl-D-aspartate receptors is reduced by monosialogangliosides.

Skaper, S. D., Leon, A., & Facci, L. (1991) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)20463-3 · Cited by 25 · see citing works

Effects of Unilateral Entorhinal Cortex Lesion and Ganglioside GM1 Treatment on Performance in a Novel Water Maze Task

Glasier, M. M., SUTTON, R. L., & Stein, D. G. (1995) · Neurobiology of Learning and Memory · doi:10.1006/nlme.1995.0003 · Cited by 23 · see citing works

Induction of the ganglioside marker A2B5 on cultured cerebellar neural cells by growth factors

Drago, J., Reid, K., & Bartlett, P. F. (1989) · Neuroscience Letters · doi:10.1016/0304-3940(89)90825-2 · Cited by 22 · see citing works

Antibodies to GM1(NeuGc) in Guillain–Barré syndrome after ganglioside therapy

Odaka, M., Yuki, N., Nobile‐Orazio, E., et al. (2000) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(00)00287-2 · Cited by 18 · see citing works

Monosialoganglioside (GM1) restores membrane fatty acid levels in ischemic tissue after cortical focal ischemia in rat

Mahadik, S. P., Hungund, B. L., Gokhale, V. S., et al. (1993) · Neurochemistry International · doi:10.1016/0197-0186(93)90094-l · Cited by 18 · see citing works

GM1 Produces Attenuation of Short-Term Memory Deficits in Hebb–Williams Maze Performance after Unilateral Entorhinal Cortex Lesions

Glasier, M. M., Janis, L. S., GONCALVES, M., & Stein, D. G. (1999) · Physiology & Behavior · doi:10.1016/s0031-9384(98)00304-7 · Cited by 12 · see citing works

Identification of mouse type‐2‐like astrocytes: Demonstration of glutamate and GABA transmitter activated responses

Magoski, N. S., Walz, W., & Juurlink, B. H. J. (1992) · Journal of Neuroscience Research · doi:10.1002/jnr.490330112 · Cited by 12 · see citing works

Physiological relevance of apolipoprotein E recycling: studies in primary mouse hepatocytes

Zhu, M.-Y., Hasty, A. H., Harris, C. M., Linton, M. F., Fazio, S., & Swift, L. L. (2005) · Metabolism · doi:10.1016/j.metabol.2005.04.019 · Cited by 12 · see citing works

Induction of Memory and Cortical Cholinergic Neurochemical Recovery with Combine Fetal Transplantation and GM1 Treatments in Rats with Lesions of the NBM

Santucci, A. C., Gluck, R., Kanof, P. D., et al. (1993) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000107333 · Cited by 5 · see citing works

Behavioral effects of GM1 ganglioside treatment and intrahippocampal septal grafts in rats with fimbria-fornix lesions

Roeser, C., Cassel, J., & Kelche, C. R. (1997) · Experimental Brain Research · doi:10.1007/pl00005722 · Cited by 3 · see citing works

Using mice to model Alzheimer's dementia: an overview of the clinical disease and the preclinical behavioral changes in 10 mouse models

Webster, S. J., Bachstetter, A. D., Nelson, P. T., Schmitt, F. A., & Van Eldik, L. J. (2014) · Frontiers in Genetics · doi:10.3389/fgene.2014.00088 · Cited by 755 · see citing works

Endogenous anxiety and stress responses in water maze and Barnes maze spatial memory tasks

Harrison, F. E., Hosseini, A. H., & McDonald, M. P. (2009) · Behavioural Brain Research · doi:10.1016/j.bbr.2008.10.015 · Cited by 399 · see citing works

The multi-tasked life of GM1 ganglioside, a true factotum of nature

Ledeen, R. W., & Wu, G. (2015) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2015.04.005 · Cited by 212 · see citing works

Endo‐lysosomal and autophagic dysfunction: a driving factor in Alzheimer's disease?

Whyte, L. S., Lau, A. A., Hemsley, K. M., Hopwood, J. J., & Sargeant, T. J. (2017) · Journal of Neurochemistry · doi:10.1111/jnc.13935 · Cited by 150 · see citing works

Elevation of brain magnesium prevents synaptic loss and reverses cognitive deficits in Alzheimer’s disease mouse model

Li, W., Yu, J., Liu, Y., Huang, X., Abumaria, N., Zhu, Y., Huang, X., Xiong, W., Ren, C., Liu, X.-G., et al. (2014) · Molecular Brain · doi:10.1186/s13041-014-0065-y · Cited by 146 · see citing works

Implications of Glycosylation in Alzheimer’s Disease

Haukedal, H., & Freude, K. K. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.625348 · Cited by 114 · see citing works

Defective macroautophagic turnover of brain lipids in the TgCRND8 Alzheimer mouse model: prevention by correcting lysosomal proteolytic deficits

Yang, D.-S., Stavrides, P., Saito, M., Kumar, A., Rodriguez-Navarro, J. A., Pawlik, M., Huo, C., Walkley, S. U., Saito, M., Cuervo, A. M., et al. (2014) · Brain · doi:10.1093/brain/awu278 · Cited by 114 · see citing works

APP Function and Lipids: A Bidirectional Link

Grimm, M. O. W., Mett, J., Grimm, H. S., & Hartmann, T. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00063 · Cited by 104 · see citing works

Abnormal vibrissa‐related behavior and loss of barrel field inhibitory neurons in <scp>5xFAD</scp> transgenics

Flanigan, T. J., Xue, Y., Kishan Rao, S., Dhanushkodi, A., & McDonald, M. P. (2014) · Genes, Brain and Behavior · doi:10.1111/gbb.12133 · Cited by 104 · see citing works

Siglec receptors and hiding plaques in Alzheimer's disease

Salminen, A., & Kaarniranta, K. (2009) · Journal of Molecular Medicine · doi:10.1007/s00109-009-0472-1 · Cited by 73 · see citing works

Deletion of Specific Sphingolipids in Distinct Neurons Improves Spatial Memory in a Mouse Model of Alzheimer’s Disease

Herzer, S., Hagan, C., von Gerichten, J., Dieterle, V., Munteanu, B., Sandhoff, R., Hopf, C., & Nordström, V. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00206 · Cited by 27 · see citing works

Alteration of cortical EEG in mice carrying mutated human APP transgene

Wang, J., Ikonen, S., Gurevicius, K., van Groen, T., & Tanila, H. (2002) · Brain Research · doi:10.1016/s0006-8993(02)02617-3 · Cited by 59 · see citing works

Mutant Presenilin 2 Transgenic Mouse: Effect on an Age‐Dependent Increase of Amyloid β‐Protein 42 in the Brain

Oyama, F., Sawamura, N., Kobayashi, K., Morishima‐Kawashima, M., Kuramochi, T., Ito, M., Tomita, T., Maruyama, K., Saido, T. C., Iwatsubo, T., et al. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.71010313.x · Cited by 92 · see citing works

Early-onset amyloid deposition in TGCRND8 mice expressing a mutant amyloid precursor protein transgene (APP695KM670/671NL + V717F)

Chrishti, M. A., Yang, D., Strome, R., et al. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)82365-9

Expression of APP in Brains of Transgenic Mice Containing the Entire Human APP Gene

Buxbaum, J. D., Christensen, J., Ruefli, A. A., Greengard, P., & Loring, J. F. (1993) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1993.2527 · Cited by 63 · see citing works

Mouse models of Alzheimer's disease for preclinical research

Watamura, N., Sato, K., & Saido, T. C. (2022) · Neurochemistry International · doi:10.1016/j.neuint.2022.105361 · Cited by 29 · see citing works